- Home
- MLGO vs ABOS Comparison
MLGO vs ABOS Comparison
Compare MLGO & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- ABOS
- Stock Information
- Founded
- MLGO 2018
- ABOS 1996
- Country
- MLGO China
- ABOS United States
- Employees
- MLGO N/A
- ABOS N/A
- Industry
- MLGO EDP Services
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- MLGO Technology
- ABOS Health Care
- Exchange
- MLGO Nasdaq
- ABOS Nasdaq
- Market Cap
- MLGO 118.6M
- ABOS 103.6M
- IPO Year
- MLGO N/A
- ABOS 2021
- Fundamental
- Price
- MLGO $10.95
- ABOS $1.88
- Analyst Decision
- MLGO
- ABOS Strong Buy
- Analyst Count
- MLGO 0
- ABOS 3
- Target Price
- MLGO N/A
- ABOS $8.00
- AVG Volume (30 Days)
- MLGO 716.3K
- ABOS 410.3K
- Earning Date
- MLGO 12-16-2025
- ABOS 11-11-2025
- Dividend Yield
- MLGO N/A
- ABOS N/A
- EPS Growth
- MLGO N/A
- ABOS N/A
- EPS
- MLGO 4.04
- ABOS N/A
- Revenue
- MLGO $61,302,336.00
- ABOS N/A
- Revenue This Year
- MLGO N/A
- ABOS N/A
- Revenue Next Year
- MLGO N/A
- ABOS N/A
- P/E Ratio
- MLGO $2.71
- ABOS N/A
- Revenue Growth
- MLGO N/A
- ABOS N/A
- 52 Week Low
- MLGO $7.82
- ABOS $0.86
- 52 Week High
- MLGO $972.00
- ABOS $3.36
- Technical
- Relative Strength Index (RSI)
- MLGO 57.90
- ABOS 67.95
- Support Level
- MLGO $9.02
- ABOS $1.67
- Resistance Level
- MLGO $11.33
- ABOS $1.86
- Average True Range (ATR)
- MLGO 0.99
- ABOS 0.16
- MACD
- MLGO 0.00
- ABOS 0.06
- Stochastic Oscillator
- MLGO 42.58
- ABOS 73.86
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.